Literature DB >> 6151665

Comparative studies with somatostatin and cysteamine in different behavioral tests on rats.

L Vécsei, C Király, I Bollók, A Nagy, J Varga, B Penke, G Telegdy.   

Abstract

In the present study the effects of somatostatin and cysteamine (a selective decreaser of the somatostatin level in the body) were compared in different behavioral tests on rats. Somatostatin inhibited the extinction of active avoidance behavior 8 hr and 24 hr after intracerebroventricular (ICV) treatment, while cysteamine facilitated it 4 hr and 8 hr after subcutaneous (SC) treatment. Somatostatin did not significantly influence the cysteamine-induced facilitation of the extinction. Somatostatin did not have a significant effect on T-maze spatial discrimination learning and reverse learning, whereas cysteamine markedly attenuated the performance 4 hr (1st day) after treatment. Somatostatin in a dose of 4 micrograms (ICV) increased the locomotor activity 10 min after treatment, while cysteamine markedly decreased all parameters of the open-field test. These effects of the drug had disappeared 24 hr after treatment. If different doses of somatostatin (4 micrograms or 10 micrograms ICV) were administered to cysteamine-pretreated rats, the peptide did not modify the drug-induced changes in the open-field test. The data suggest that the brain somatostatin might have a physiological role in the organization of certain types of behavior.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6151665     DOI: 10.1016/s0091-3057(84)80061-1

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  9 in total

1.  Somatostatin-28 modulates prepulse inhibition of the acoustic startle response, reward processes and spontaneous locomotor activity in rats.

Authors:  Svetlana Semenova; Daniel Hoyer; Mark A Geyer; Athina Markou
Journal:  Neuropeptides       Date:  2010-10       Impact factor: 3.286

2.  Influence of cysteamine and cysteine on open-field behaviour, and on brain concentrations of catecholamines, somatostatin, neuropeptide Y, and corticotropin releasing hormone in the rat.

Authors:  L Vécsei; R Ekman; C Alling; E Widerlöv
Journal:  J Neural Transm Gen Sect       Date:  1989

3.  Somatostatinergic systems: an update on brain functions in normal and pathological aging.

Authors:  Guillaume Martel; Patrick Dutar; Jacques Epelbaum; Cécile Viollet
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-06       Impact factor: 5.555

Review 4.  Somatostatin-Expressing Inhibitory Interneurons in Cortical Circuits.

Authors:  Iryna Yavorska; Michael Wehr
Journal:  Front Neural Circuits       Date:  2016-09-29       Impact factor: 3.492

5.  Somatostatin 1.1 contributes to the innate exploration of zebrafish larva.

Authors:  Feng B Quan; Laura Desban; Olivier Mirat; Maxime Kermarquer; Julian Roussel; Fanny Koëth; Hugo Marnas; Lydia Djenoune; François-Xavier Lejeune; Hervé Tostivint; Claire Wyart
Journal:  Sci Rep       Date:  2020-09-17       Impact factor: 4.379

Review 6.  Diet, Stress and Mental Health.

Authors:  J Douglas Bremner; Kasra Moazzami; Matthew T Wittbrodt; Jonathon A Nye; Bruno B Lima; Charles F Gillespie; Mark H Rapaport; Bradley D Pearce; Amit J Shah; Viola Vaccarino
Journal:  Nutrients       Date:  2020-08-13       Impact factor: 5.717

7.  Beneficial effect of Indigo Naturalis on acute lung injury induced by influenza A virus.

Authors:  Peng Tu; Rong Tian; Yan Lu; Yunyi Zhang; Haiyan Zhu; Lijun Ling; Hong Li; Daofeng Chen
Journal:  Chin Med       Date:  2020-12-21       Impact factor: 5.455

Review 8.  Somatostatin and Somatostatin-Containing Neurons in Shaping Neuronal Activity and Plasticity.

Authors:  Monika Liguz-Lecznar; Joanna Urban-Ciecko; Malgorzata Kossut
Journal:  Front Neural Circuits       Date:  2016-06-30       Impact factor: 3.492

9.  Hippocampal Somatostatin Interneurons, Long-Term Synaptic Plasticity and Memory.

Authors:  Eve Honoré; Abdessattar Khlaifia; Anthony Bosson; Jean-Claude Lacaille
Journal:  Front Neural Circuits       Date:  2021-06-02       Impact factor: 3.492

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.